Info przyszło:
https://www.bankier.pl/wiadomosc/MILESTONE-MEDICAL-Reporting-Ninth-Published-Study-Reinforcing-Efficacy-of-CompuFlo-Epidural-Instrument-as-an-Objective-Tool-to-Identify-the-Epidural-Space-and-Reduce-Risk-of-Accidental-Dural-Puncture-7802159.html
"As noted in the article, the authors are not aware of any other devices on the market that can effectively distinguish between a true loss-of-resistance and a false loss-of-resistance as demonstrated by the CompuFlo® Epidural Instrument."
Tak jak zapowiadali Osser i Johnstone: " Chcemy, by nasze Compuflo epidural stało się standartem w opiece medycznej"
Walczymy o CAŁY rynek epiduralu w USA i na świecie.
W USA to dziś miliardy USD. Na świecie?